Maurice D. Lutgens
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
Journal: Digestive diseases and sciences
Published: December 08, 2023
Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 11, 2023
The Efficacy of an Over-the-Counter Multivitamin and Mineral Supplement to Prevent Infections in Patients With Inflammatory Bowel Disease in Remission With Immunomodulators and/or Biological Agents: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Journal: Inflammatory bowel diseases
Published: June 08, 2023
Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.
Journal: Alimentary pharmacology & therapeutics
Published: June 04, 2023
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
Journal: Journal of Crohn's & colitis
Published: February 06, 2023
Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease.
Journal: Journal of Crohn's & colitis
Published: December 15, 2022
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
Journal: The lancet. Gastroenterology & hepatology
Published: November 02, 2022
Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: April 16, 2022
Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment.
Journal: Inflammatory bowel diseases
Published: July 06, 2021
Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives.
Journal: European journal of internal medicine
Published: June 04, 2021
Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease.
Journal: Inflammatory bowel diseases
Published: November 17, 2020
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
Journal: Journal of Crohn's & colitis
Published: October 20, 2020
Last Updated: 09/26/2026